Emcure Pharmaceuticals (Emcure Pharma) IPO Date, Review, Price, Allotment Details

Emcure Pharmaceuticals is an Indian pharmaceutical company engaged in developing, manufacturing and globally marketing a broad range of pharmaceutical products across several major therapeutic areas. They are a research and development (R&D) driven company with a differentiated product portfolio that includes orals, injectables, and biotherapeutics, which has enabled them to reach a range of target markets across over 70 countries, with a strong 218 presence in India, Europe, and Canada.

They were ranked as (i) the 13th largest pharmaceutical company in India in terms of Domestic Sales for MAT Financial Year 2024, (ii) the 4th largest pharmaceutical company by market share in their Covered Markets in terms of Domestic Sales for MAT Financial Year 2024, and (iii) the largest pharmaceutical company in the gynecology and human immunodeficiency virus (HIV) antivirals therapeutic areas in India in terms of Domestic Sales for MAT Financial Year 2024 (Source: CRISIL Report). They are led by Promoters with significant experience in the pharmaceutical industry who are supported by a strong professional management team.

Their competitive advantage in the domestic market stems from their differentiated product portfolio, which has allowed us to establish their presence in most of the major therapeutic areas, including gynecology, cardiovascular, vitamins, minerals and nutrients, HIV antivirals, blood-related and oncology/anti-neoplastics. Across the gynecology, vitamins, minerals, and nutrients, HIV antivirals, blood-related, and oncology/antineoplastics therapeutic areas, they were ranked among the 10 largest pharmaceutical companies in India in terms of Domestic Sales for MAT Financial Year 2024 (Source: CRISIL Report).

Sales of their iron, chiral, biotherapeutics, injectables, and photo-chemistry products contributed to 52.97% of their revenue from sales in India for the Financial Year 2024, demonstrating their approach towards establishing a differentiated product portfolio. They are focused on pharmaceutical products used in chronic (including sub-chronic) therapeutic areas. Chronic therapeutic areas in the IPM are expected to register higher growth than acute therapeutic areas over the next five Financial Years (Source: CRISIL Report). Chronic therapeutic areas contributed to ₹25,460.48 million or 46.22% of their total Domestic Sales for MAT Financial Year 2024 (Source: CRISIL Report).

Objects of the Issue

• Repayment and/ or prepayment of all or a portion of certain outstanding borrowings availed by the company.
• General corporate purposes.

Emcure Pharmaceuticals (Emcure Pharma) IPO Review (Apply or Not)

• To be updated soon

Brokerage Firm IPO Review

• Capital Market: To be updated soon
• Religare Broking: To be updated soon
• Hem Securities: To be updated soon
• Arihant Capital: To be updated soon

Emcure Pharmaceuticals (Emcure Pharma) IPO Date & Price Band Details

Emcure Pharmaceuticals (Emcure Pharma) IPO Market Lot

The Emcure Pharmaceuticals IPO minimum market lot is 14 shares with ₹14,112 application amount. The retail investors can apply up-to 14 lots with 196 shares or ₹197,568 amount.

Emcure Pharmaceuticals IPO Allotment & Listing Dates

The Emcure Pharmaceuticals IPO date is July 3 and the close date is July 5. The Emcure Pharmaceuticals IPO allotment will be finalized on July 8 and the IPO listing on July 10.

You can check IPO subscription status and IPO allotment status on their respective pages.

Emcure Pharmaceuticals IPO Form

How to apply for the Emcure Pharmaceuticals IPO? You can apply for Emcure Pharmaceuticals IPO via ASBA available in your bank account. Just go to the online bank login and apply via your bank account by selecting the Emcure Pharmaceuticals IPO in the Invest section. The other option is you can apply for Emcure Pharmaceuticals IPO via IPO forms downloaded via NSE and BSE. Check out the Emcure Pharmaceuticals forms – Click BSE Forms & NSE Forms blank IPO forms download, fill, and submit in your bank or with your broker.

Emcure Pharmaceuticals Company Financial Report

Emcure Pharmaceuticals (Emcure Pharma) IPO Valuation – FY2024

Check Emcure Pharmaceuticals IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.

Peer Group

• Dr. Reddy’s Laboratories Limited
• Cipla Limited
• Alkem Laboratories Limited
• Torrent Pharmaceuticals Limited
• Mankind Pharma Limited
• Abbott India Limited
• J. B. Chemicals & Pharmaceutical s Limited

Company Promoters

• Satish Mehta
• Sunil Mehta

Emcure Pharmaceuticals (Emcure Pharma) IPO Registrar

Link Intime India Private Ltd
Phone: +91-22-4918 6270
Email: [email protected]
Website: https://linkintime.co.in/

Emcure Pharmaceuticals (Emcure Pharma) IPO Allotment Status Check

Check Emcure Pharmaceuticals IPO allotment status on Linkintime website allotment URL. Click Here

Emcure Pharmaceuticals IPO Lead Managers aka Merchant Bankers

• Kotak Mahindra Capital Company Limited 
• Axis Capital Limited 
• J.P. Morgan India Private Limited
• Jefferies India Private Limited 

Company Address

Emcure Pharmaceuticals Limited
Plot No. P-1 and P-2,
IT-BT Park, Phase II, M.I.D.C.,
Hinjawadi, Pune -411 057
Phone: +91 20 3507 0033
Email: [email protected]
Website: https://www.emcure.com/

Emcure Pharmaceuticals (Emcure Pharma) IPO FAQs